Evidence Lens

Midlife health advice can be overwhelming. Evidence Lens helps women ages 40-65 make sense of supplements, habits, and wellness options by showing what clinical trials and research publications actually say.

Try asking

What you’ll get

Clear signals from human studies — without hype.

Evidence summary
A plain-language readout of what sources suggest — and what’s uncertain.
Relevance, confidence & quality
Relevance to your question (summary + per-study scores and reasons), confidence on each study and in the snapshot, plus a quality breakdown — so fit and strength are explicit.
Daily digest
Save a search you want to track and get a daily email when new matching studies appear — so you don’t have to rerun the same query to stay current.
Example preview

Does magnesium help with sleep?

Same study card layout as after you search — illustrative seed, not your query.

Mixed evidence · small trials common
High relevanceModerate confidenceRandomized controlled trial
PubMed
The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial

Key Takeaway

Elderly participants taking 500mg magnesium daily for 8 weeks showed improved sleep quality scores and reduced sleep onset time compared to placebo.

Why this looks relevant

Structured score: 10/10

  • Population is a direct match for people asking this question.
  • Intervention directly tests the health practice in the query.
  • Outcome directly measures the target benefit users care about.
  • Published human results are available.

Why confidence is moderate

Structured score: 4/7

  • Randomized controlled design supports stronger causal inference than observational data.
  • Small sample size limits how much confidence to place in the finding.
  • Published human results are available.
  • Outcome uses a mix of objective and subjective measures.
  • Small sample size reduces certainty.
  • Single-center design may limit generalizability.
  • Short follow-up limits confidence about durability of the effect.

Sample Size

46 participants

Population

Adults aged 60-75 with insomnia

Intervention

500mg magnesium oxide daily for 8 weeks

Outcome Measured

Pittsburgh Sleep Quality Index (PSQI), sleep onset latency

Limitations

  • Small sample size
  • Single-center study
  • Used magnesium oxide (lower bioavailability)
  • Short duration
View source